These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 16126986

  • 1. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [Abstract] [Full Text] [Related]

  • 2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 3. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR.
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [Abstract] [Full Text] [Related]

  • 4. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E, Kobayashi K, Tabuchi M, Lopez LR.
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [Abstract] [Full Text] [Related]

  • 5. Autoimmune-mediated atherothrombosis.
    Matsuura E, Lopez LR.
    Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
    [Abstract] [Full Text] [Related]

  • 6. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
    Matsuura E, Kobayashi K, Inoue K, Lopez LR, Shoenfeld Y.
    Lupus; 2005 Oct; 14(9):736-41. PubMed ID: 16218478
    [Abstract] [Full Text] [Related]

  • 7. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
    Lopez D, Kobayashi K, Merrill JT, Matsuura E, Lopez LR.
    Clin Dev Immunol; 2003 Oct; 10(2-4):203-11. PubMed ID: 14768953
    [Abstract] [Full Text] [Related]

  • 8. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
    Lopez LR, Salazar-Paramo M, Palafox-Sanchez C, Hurley BL, Matsuura E, Garcia-De La Torre I.
    Lupus; 2006 Oct; 15(2):80-6. PubMed ID: 16539278
    [Abstract] [Full Text] [Related]

  • 9. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V, Bison E, Ruffatti A, Iliceto S.
    Thromb Res; 2008 Oct; 122(4):556-9. PubMed ID: 18328538
    [Abstract] [Full Text] [Related]

  • 10. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E, Kobayashi K, Hurley BL, Lopez LR.
    Lupus; 2006 Oct; 15(7):478-83. PubMed ID: 16898186
    [Abstract] [Full Text] [Related]

  • 11. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
    Kobayashi K, Tada K, Itabe H, Ueno T, Liu PH, Tsutsumi A, Kuwana M, Yasuda T, Shoenfeld Y, de Groot PG, Matsuura E.
    Lupus; 2007 Oct; 16(12):929-38. PubMed ID: 18042586
    [Abstract] [Full Text] [Related]

  • 12. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
    Kobayashi K, Lopez LR, Matsuura E.
    Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
    [Abstract] [Full Text] [Related]

  • 13. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
    Bećarevic M, Andrejević S, Bonaci-Nikolić B, Obradović I, Miljić P, Majkić-Singh N.
    Clin Lab; 2005 Jun; 51(5-6):279-83. PubMed ID: 15991801
    [Abstract] [Full Text] [Related]

  • 14. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
    Lopez LR, Hurley BL, Simpson DF, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
    [Abstract] [Full Text] [Related]

  • 15. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?
    Matsuura E, Lopez LR.
    Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445
    [Abstract] [Full Text] [Related]

  • 16. Oxidized LDL induces in vitro lymphocyte activation in antiphospholipid syndrome.
    Laczik R, Szodoray P, Veres K, Lakos G, Sipka S, Szegedi G, Soltész P.
    Autoimmunity; 2010 Jun; 43(4):334-9. PubMed ID: 20187701
    [Abstract] [Full Text] [Related]

  • 17. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
    Romero FI, Atsumi T, Tinahones FJ, Gómez-Zumaquero JM, Amengual O, Khamashta MA, Hughes GR.
    Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
    [Abstract] [Full Text] [Related]

  • 18. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
    Kajiwara T, Yasuda T, Matsuura E.
    J Autoimmun; 2007 Dec; 29(2-3):164-73. PubMed ID: 17826950
    [Abstract] [Full Text] [Related]

  • 19. Antiphospholipid antibodies in arterial thrombosis.
    Koike T.
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [Abstract] [Full Text] [Related]

  • 20. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S, Iaccarino L, Ghirardello A, Tarricone E, Arienti S, Sarzi-Puttini P, Gambari P, Doria A.
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.